Great Point Partners’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-187,843
Closed -$2M 36
2024
Q4
$2M Sell
187,843
-570,943
-75% -$6.84M 0.94% 26
2024
Q3
$9.64M Sell
758,786
-2,147,473
-74% -$31.9M 2.91% 16
2024
Q2
$48.8M Buy
2,906,259
+285,714
+11% +$4.06M 9.34% 1
2024
Q1
$39.3M Hold
2,620,545
6.13% 3
2023
Q4
$39.3M Hold
2,620,545
6.7% 3
2023
Q3
$36.7M Buy
+2,620,545
New +$42.1M 6.91% 1
2023
Q2
Sell
-39,222
Closed -$362K 53
2023
Q1
$362K Sell
39,222
-520,778
-93% -$4.79M 0.07% 44
2022
Q4
$4.97M Sell
560,000
-313,424
-36% -$2.97M 1.03% 35
2022
Q3
$7.27M Hold
873,424
1.75% 21
2022
Q2
$7.15M Hold
873,424
1.84% 23
2022
Q1
$7.61M Hold
873,424
1.84% 21
2021
Q4
$8.31M Buy
873,424
+123,424
+16% +$1.74M 1.86% 24
2021
Q3
$12.6M Buy
+750,000
New +$11.9M 2.98% 14

Other funds holding URGN